中一科技(301150.SZ):中一投資擬減持不超過1.5%股份
格隆匯6月26日丨中一科技(301150.SZ)公佈,股東雲夢中一科技投資中心(有限合夥)(簡稱“中一投資”)計劃在本公吿披露之日起15個交易日後3個月內(即2025年7月18日至2025年10月17日)以集中競價、大宗交易方式合計減持不超過3,498,500股(佔公司總股本的1.5000%,佔剔除公司回購專用賬户中股份數量後總股本的1.5493%)(如遇派息、送股、轉增股本、配股等除權除息事項,上述擬減持股份數量將相應進行調整,但減持股份佔公司總股本的比例不變)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.